Format
Sort by

Send to

Choose Destination

Search results

Items: 2

1.

Use of Adjuvant Bisphosphonates and Other Bone-Modifying Agents in Breast Cancer: A Cancer Care Ontario and American Society of Clinical Oncology Clinical Practice Guideline.

Dhesy-Thind S, Fletcher GG, Blanchette PS, Clemons MJ, Dillmon MS, Frank ES, Gandhi S, Gupta R, Mates M, Moy B, Vandenberg T, Van Poznak CH.

J Clin Oncol. 2017 Jun 20;35(18):2062-2081. doi: 10.1200/JCO.2016.70.7257. Epub 2017 Mar 6. Review.

PMID:
28618241
2.

American Society of Clinical Oncology endorsement of the cancer care Ontario practice guideline on adjuvant ovarian ablation in the treatment of premenopausal women with early-stage invasive breast cancer.

Griggs JJ, Somerfield MR, Anderson H, Henry NL, Hudis CA, Khatcheressian JL, Partridge AH, Prestrud AA, Davidson NE.

J Clin Oncol. 2011 Oct 10;29(29):3939-42. doi: 10.1200/JCO.2011.36.4950. Epub 2011 Sep 6. Review. Erratum in: J Clin Oncol. 2012 Apr 20;30(12):1398.

PMID:
21900112

Supplemental Content

Loading ...
Support Center